Anixa Biosciences Inc
Company Stats
- Market Cap
- $101.9M
- as of Sep 30, 2026
- Shares Outstanding
- 34.8M
- Free Float
- 42.1%
Income Statement
- Operating Income
- -$11.7M
- Net Income
- -$10.9M
Balance Sheet
- Cash & Equivalents
- $1.2M
Returns & Capital
- SBC, 3Y Avg
- $4.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2024 | $210,000 | — | — |
| FY2023 | $210,000 | — | — |
| FY2021 | $512,000 | — | — |
Annual filing data through FY ended October 31, 2025; shares and float as of October 20, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Elevance Health Insiders Lead Weekly Buying Clusters